Walgreens Boots Alliance Inc. (NASDAQ:WBA) has been assigned a consensus recommendation of “Buy” from the twenty-two ratings firms that are currently covering the firm. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $93.45.
Several equities analysts recently commented on WBA shares. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Thursday, October 6th. Deutsche Bank AG reiterated a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a report on Wednesday, September 28th. Robert W. Baird reiterated an “outperform” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a report on Saturday, September 10th. Leerink Swann reiterated an “outperform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, August 30th. Finally, Credit Suisse Group AG reiterated a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a report on Monday, October 3rd.
Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at 78.31 on Wednesday. The firm has a 50-day moving average of $80.83 and a 200 day moving average of $81.04. Walgreens Boots Alliance has a one year low of $71.50 and a one year high of $95.74. The stock has a market capitalization of $84.76 billion, a price-to-earnings ratio of 27.06 and a beta of 1.01.
The business also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Shareholders of record on Thursday, November 17th will be paid a dividend of $0.375 per share. The ex-dividend date of this dividend is Tuesday, November 15th. This represents a $1.50 dividend on an annualized basis and a yield of 1.92%. Walgreens Boots Alliance’s payout ratio is 51.90%.
In other news, EVP Kathleen Wilson-Thompson sold 23,996 shares of the stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $85.00, for a total value of $2,039,660.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director William C. Foote sold 2,067 shares of the stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $81.35, for a total transaction of $168,150.45. Following the completion of the sale, the director now owns 26,690 shares in the company, valued at approximately $2,171,231.50. The disclosure for this sale can be found here. Company insiders own 21.10% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the company. CapWealth Advisors LLC raised its stake in Walgreens Boots Alliance by 30.0% in the first quarter. CapWealth Advisors LLC now owns 1,300 shares of the pharmacy operator’s stock worth $110,000 after buying an additional 300 shares during the last quarter. Kings Point Capital Management raised its stake in Walgreens Boots Alliance by 12.8% in the first quarter. Kings Point Capital Management now owns 1,323 shares of the pharmacy operator’s stock worth $111,000 after buying an additional 150 shares during the last quarter. Jolley Asset Management LLC raised its stake in Walgreens Boots Alliance by 104.5% in the second quarter. Jolley Asset Management LLC now owns 1,370 shares of the pharmacy operator’s stock worth $114,000 after buying an additional 700 shares during the last quarter. Westbourne Investment Advisors Inc. acquired a new stake in Walgreens Boots Alliance during the second quarter worth $121,000. Finally, Cribstone Capital Management LLC acquired a new stake in Walgreens Boots Alliance during the second quarter worth $149,000. Hedge funds and other institutional investors own 59.74% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.